Three PDE5 inhibitors, not two
Every other combination product we have audited stacks two drugs of the same class — sildenafil and tadalafil. This one adds vardenafil as well.
All three do the identical thing: they block the PDE5 enzyme. Adding a third is not a third mechanism, it is a third helping of the same one. No guideline supports combining two, let alone three, and there is no approved product that does it.
The predictable consequences of more PDE5 inhibition are the known dose-related effects of the class: lower blood pressure, more headache and flushing, and a greater chance of a prolonged erection. Because no doses are published, you cannot judge how much of each you are getting.
Apomorphine
The fourth ingredient is the only one working differently — apomorphine is a dopamine agonist acting on the brain rather than the blood vessels. It has genuine history in this field, having been developed for ED and sold in Europe as Uprima.
It was never approved in the United States, in part because of nausea and fainting. Fainting matters here: it is a blood-pressure effect, being added to three drugs that also lower blood pressure.
The wrong FDA disclaimer
The page says clearly and repeatedly that the product is compounded, which is more than MEDVi manages. But the FDA sentence in the footer is this one:
“These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.”
That is the dietary supplement disclaimer. It is the wrong instrument for a prescription product containing four active drugs, and the phrase “not intended to treat any disease” sits oddly beside a page selling treatment for erectile dysfunction.
The disclosure a reader actually needs is the one BlueChew, Ro, Motivated and Provn all carry: that the FDA does not approve or evaluate compounded drugs for safety, effectiveness or quality. What compounded means.
What it does well
A US board-certified physician reviews the questionnaire, and in some states a video consultation or live chat is required rather than optional — which is a real standard, not a marketing line.
There are also no invented testimonials, no countdown timers and no manufactured scarcity. The price is on the page. Compared with the pressure tactics elsewhere in this category, the tone is restrained.
The corporate structure is disclosed too: the platform is operated separately from the medical entities that employ the prescribing clinicians. Common in telehealth, and worth understanding — the brand is not the party making the clinical decision.
Our honest recommendation
We would not tell you this is the best product in the category, because our own checks do not support that. It is the joint most expensive, it publishes no doses, and its page tells you nothing about what can go wrong.
If you want a physician-supervised compounded product and you have already worked through single drugs at proper doses, it is a legitimate service with real clinical oversight. If you are starting out, start with one drug — cheaper, better evidenced, and it actually tells you something. How the single drugs compare.